Publications by authors named "Jenna R Tew"
Article Synopsis
- The study investigates the prognostic value of the blood urea nitrogen to serum albumin ratio (BAR) in predicting outcomes for lung cancer patients who undergo robotic-assisted pulmonary lobectomy (RAPL).
- An analysis of 400 patients revealed that while there was a clear threshold for BAR, there were no significant differences in surgical complications or 30-day mortality outcomes between those with Low and High BAR.
- The conclusion is that High BAR does not effectively predict worse outcomes in this context, suggesting the need for further research to explore its prognostic capabilities in lower-risk patient populations.
Background: Lung-sparing procedures, specifically segmentectomies and wedge resections, have increased over the years to treat early-stage non-small cell lung cancer (NSCLC). We investigate here the perioperative and long-term outcomes of patients who underwent robotic-assisted segmentectomy (RAS) at an NCI-designated cancer center and aim to show associations between the preoperative standard update value (SUV) to tumor stage, recurrence patterns, and overall survival.
Methods: A retrospective analysis was performed on 166 consecutive patients who underwent RAS at a single institution from 2010 to 2021.
Article Synopsis
- The COVID-19 pandemic created challenges for patients seeking healthcare, prompting a study on its impact on outcomes for patients undergoing robotic-assisted pulmonary lobectomy (RAPL).
- Researchers analyzed data from 721 patients, categorizing them into those treated before and during the pandemic to assess various health factors and surgical results.
- Findings revealed that although COVID-19-Era patients had more preoperative health issues, they experienced lower intraoperative blood loss and reduced rates of new-onset atrial fibrillation, suggesting RAPL remained a safe procedure during this time, though further investigation into risks of postoperative complications like empyema is warranted.
Article Synopsis
- * Patients were divided into two groups based on FEV1%: normal (≥80%) and reduced (<80%). The reduced FEV1% group experienced more complications like prolonged air leaks and pneumonia, and had longer surgery times and higher blood loss.
- * Overall survival was significantly lower for those with reduced FEV1%, averaging 58.9 months compared to 93.2 months for those with normal FEV1%, highlighting the importance of preoperative PFTs in identifying at